The NDORMS response to COVID-19
A number of members of the department are actively helping with the response to the COVID pandemic. Playing a key role in research, literature reviews, clinical trials and engineering projects, all have a shared commitment to collaborate globally to tackle the pandemic.
Read moreKennedy Institute of Rheumatology
A world-leading medical research centre where discovery research drives the development of transformative therapies for chronic inflammatory and degenerative disease.
240 Staff, students and academic visitors
30 Nationalities
£80M+ in Research Income
Select Publications
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals.
Demetriou P. et al, (2020), Nat Immunol, 21, 1232 - 1243
The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer.
McCuaig S. et al, (2020), Clin Cancer Res
IL-33 promotes anemia during chronic inflammation by inhibiting differentiation of erythroid progenitors.
Swann JW. et al, (2020), J Exp Med, 217
Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300.
Williams LM. et al, (2020), Proc Natl Acad Sci U S A
Cellular census of human fibrosis defines functionally distinct stromal cell types and states.
Layton TB. et al, (2020), Nat Commun, 11
Latest news
CD2 corolla calls T cells to arms
20 October 2020
Kennedy researcher receives MRC Clinical Training Fellowship
9 October 2020